News Detail
MUMBAI, 25 NOV 2020: Russia’s Sputnik V Covid-19 vaccine, that reported an efficacy of over 95%, will be twice as cheap as those by Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya Institute and RDIF (Russian Direct Investment Fund), will b......
View Details
Source : The Times of India
Related News
- Dentist goes into septic shock days after vaccine in AP (28-01-2021)
- FSSAI asks state authorities to form helpdesk for smoother licensing & regn (28-01-2021)
- GSK transfers malaria vaccine production to Bharat Biotech (28-01-2021)
- Mumbai: Eight doctors reject Serum Institute’s Covishield, opt for Covaxin (28-01-2021)
- Regulate health e-service aggregators, states told (28-01-2021)
- SII seeks govt nod to ‘unblind’ trial data as volunteers ask if they got vaccine or placebo (28-01-2021)
- Bharat Biotech’s Covaxin neutralises UK strain of coronavirus: Study (28-01-2021)
- WHO issues new clinical advice on treating Covid-19 patients (27-01-2021)
- EU warns drug cos of strict export rules amid vax delays (27-01-2021)
- Hundreds of undigested pills found in patient's stomach in Kolkata (27-01-2021)